MacLean Michael F
Chief Financial Officer at Avidity Biosciences, Inc.; SVP, Chief Accounting Officer at BIIB
- Sold, on record
- $16.4M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Jan 21, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Avidity Biosciences, Inc.Chief Financial Officer
- BIIBBIOGEN INC.SVP, Chief Accounting Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Avidity Biosciences, Inc.409,721 shares
- BIIB21,834 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Avidity Biosciences, Inc.UnusualNov 6, 2024 2024
Sold 106,319 shares at $45.56 ($4.8M)
MacLean Michael F, Chief Financial Officer
10b5-1 planSold 53.1% of holdings ($9.1M position)94,093 shares left4.1x usual sizeFollows a Form 144Filing
- 2 Form 4 sale Avidity Biosciences, Inc.RoutineDec 18, 2024 +42 days
Sold 11,151 shares at $32.66 ($364k)
MacLean Michael F, Chief Financial Officer
10b5-1 planSold 11.9% of holdings ($3.1M position)82,942 shares left0.3x usual sizeFiling
- 3 Form 4 sale Avidity Biosciences, Inc.RoutineJan 21, 2025 +34 days
Sold 3,287 shares at $28.59 ($94k)
MacLean Michael F, Chief Financial Officer
10b5-1 planSold 3% of holdings ($3.1M position)104,655 shares left0.1x usual sizeFiling
- 4 Form 4 sale Avidity Biosciences, Inc.RoutineMar 20, 2025 +58 days
Sold 7,935 shares at $31.06 ($246k)
MacLean Michael F, Chief Financial Officer
10b5-1 planSold 7.6% of holdings ($3.3M position)96,720 shares left0.7x usual sizeFiling
- 5 Form 144 notice Avidity Biosciences, Inc.NoticeAug 6, 2025 +139 days
Filed to sell 30,914 shares ($1.2M)
MacLean Michael F, Officer
10b5-1 plan2.7x usual sizeFiling
- 6 Form 4 sale Avidity Biosciences, Inc.RoutineAug 6, 2025 same day
Sold 30,914 shares at $42.73 ($1.3M)
MacLean Michael F, Chief Financial Officer
10b5-1 planSold 32% of holdings ($4.1M position)65,806 shares left2.7x usual sizeFollows a Form 144Filing
- 7 Form 4 sale Avidity Biosciences, Inc.RoutineJan 7, 2026 +154 days
Sold 1,974 shares at $72.23 ($143k)
MacLean Michael F, Chief Financial Officer
10b5-1 planSold 3% of holdings ($4.8M position)63,832 shares left0.2x usual sizeFiling
- 8 Form 4 sale Avidity Biosciences, Inc.RoutineJan 21, 2026 +14 days
Sold 4,542 shares at $72.45 ($329k)
MacLean Michael F, Chief Financial Officer
10b5-1 planSold 7.1% of holdings ($4.6M position)59,290 shares left0.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Jan 23, 2026 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 4,542 | $329k | 7.1% | Routine | SEC |
| Jan 7, 2026 | Jan 9, 2026 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 1,974 | $143k | 3.0% | Routine | SEC |
| Aug 6, 2025 | Aug 15, 2025 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 30,914 | $1.3M | 32.0% | Routine | SEC |
| Aug 6, 2025 | Aug 6, 2025 | Avidity Biosciences, Inc. | Officer | Form 144 notice | 30,914 | $1.2M | Notice | SEC | |
| Mar 20, 2025 | Mar 21, 2025 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 7,935 | $246k | 7.6% | Routine | SEC |
| Jan 21, 2025 | Jan 23, 2025 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 3,287 | $94k | 3.0% | Routine | SEC |
| Dec 18, 2024 | Dec 19, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 11,151 | $364k | 11.9% | Routine | SEC |
| Nov 6, 2024 | Nov 8, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 106,319 | $4.8M | 53.1% | Unusual | SEC |
| Nov 6, 2024 | Nov 6, 2024 | Avidity Biosciences, Inc. | Officer | Form 144 notice | 106,319 | $4.8M | Notice | SEC | |
| Sep 23, 2024 | Sep 23, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 11,510 | $506k | 10.7% | Routine | SEC |
| Jun 18, 2024 | Jun 20, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 11,228 | $439k | 16.3% | Routine | SEC |
| Jun 12, 2024 | Jun 14, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 104,245 | $3.7M | 70.3% | Routine | SEC |
| Jun 12, 2024 | Jun 12, 2024 | Avidity Biosciences, Inc. | Officer | Form 144 notice | 104,245 | $3M | Notice | SEC | |
| May 14, 2024 | May 16, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 75,000 | $2.1M | 63.0% | Routine | SEC |
| May 14, 2024 | May 14, 2024 | Avidity Biosciences, Inc. | Officer | Form 144 notice | 75,000 | $2M | Notice | SEC | |
| Mar 13, 2024 | Mar 15, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 40,000 | $981k | 47.6% | Routine | SEC |
| Mar 13, 2024 | Mar 13, 2024 | Avidity Biosciences, Inc. | Director | Form 144 notice | 40,000 | $908k | Notice | SEC | |
| Jan 22, 2024 | Jan 23, 2024 | Avidity Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 1,616 | $16k | 8.7% | Routine | SEC |
| Aug 2, 2010 | Aug 3, 2010 | BIIB | SVP, Chief Accounting Officer | Form 4 sale | 9,542 | $542k | 45.1% | Unusual | SEC |
| Mar 19, 2010 | Mar 23, 2010 | BIIB | SVP, Chief Accounting Officer | Form 4 sale | 4,085 | $245k | 16.7% | Plan not stated | SEC |
| Jan 19, 2010 | Jan 19, 2010 | BIIB | SVP, Chief Accounting Officer | Form 4 sale | 1,389 | $76k | 5.6% | Plan not stated | SEC |
| Oct 6, 2008 | Oct 6, 2008 | BIIB | SVP, Chief Accounting Officer | Form 4 sale | 2,047 | $102k | 8.5% | Plan not stated | SEC |
| Jul 31, 2008 | Aug 1, 2008 | BIIB | SVP, Chief Accounting Officer | Form 4 sale | 1,875 | $136k | 7.0% | Plan not stated | SEC |
| Jul 22, 2008 | Jul 24, 2008 | BIIB | SVP, Chief Accounting Officer | Form 4 sale | 682 | $48k | 2.7% | Plan not stated | SEC |
| Apr 8, 2008 | Apr 10, 2008 | BIIB | SVP, Chief Accounting Officer | Form 4 sale | 2,214 | $143k | 8.0% | Plan not stated | SEC |